Bristol Myers Squibb (BMY)

Operating Cash Flow (Statement)

$3.39B

Quarterly · Period ending: · USD

BMY logo

BMY Operating Cash Flow (Statement)

Latest reported$3.39B
BMY Quarterly Cash from Operations ($383.00M → $3.39B)
High-resolution chart · PNG

BMY operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
1,514,000,000
869,000,000
1,820,000,000
1,188,000,000
938,000,000
706,000,000
1,618,000,000
1,088,000,000
865,000,000
721,000,000
1,443,000,000
1,319,000,000
478,000,000
880,000,000
593,000,000
825,000,000
371,000,000
687,000,000
658,000,000
742,000,000
626,000,000
615,000,000
642,000,000
767,000,000
337,000,000
753,000,000
655,000,000
484,000,000
466,000,000
696,000,000
764,000,000
807,000,000
596,000,000
413,000,000
644,000,000
688,000,000
298,000,000
398,000,000
660,000,000
503,000,000
300,000,000
372,000,000
541,000,000
441,000,000
387,000,000
383,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.